Scientists have developed a new technology for anti-cancer vaccines that harnesses immunity formed after COVID-19 to fight tumors. This method has already demonstrated effectiveness in experiments and is currently undergoing clinical trials.
An alpha-coronavirus has been discovered in African bats that is capable of entering human cells via the CEACAM6 protein, which is widely present in the lungs. Although transmission of the virus to humans has not yet been observed, the study highlights the importance of monitoring new potential routes of infection.
The protein dermcidin, produced by sweat glands, can inhibit the replication of the influenza virus and other respiratory infections. Higher concentrations of this substance are associated with greater resistance to illness and the absence of pronounced symptoms.